SCHEMBL13544490

SCHEMBL13544490

Cc1nc2cc(NC(=O)c3ccc(C(C)(C)C)cc3Cl)ccc2s1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 9/20 0.72
RAB9A P51151 6/20 0.54
NPC1 O15118 4/20 0.54
CASP3 P42574 2/20 0.54
SENP7 Q9BQF6 2/20 0.54
LMNA P02545 1/20 0.51
POLB P06746 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
ALDH1A1 P00352 3/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
KDM4E B2RXH2 1/20 0.48
HTT P42858 2/20 0.48
SENP8 Q96LD8 1/20 0.47
SENP6 Q9GZR1 1/20 0.47
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
HPGD P15428 1/20 0.46
MCL1 Q07820 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
NR1H4 Q96RI1 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13544362 0.90 TRPV1 (0.80) TRPV1RAB9ANPC1CASP3SENP7
SCHEMBL13544365 0.87 TRPV1 (0.72) TRPV1RAB9ANPC1CASP3SENP7
SCHEMBL5781677 0.84 TRPV1 (1.00) TRPV1RAB9ANPC1CASP3SENP7
SCHEMBL3577539 0.83 TRPV1 (0.54) TRPV1RAB9ANPC1CASP3SENP7
SCHEMBL4988297 0.78 TRPV1 (0.88) TRPV1RAB9ANPC1CASP3SENP7
SCHEMBL5784275 0.78 TRPV1 (0.62) TRPV1RAB9ANPC1CASP3SENP7
SCHEMBL10089795 0.78 LMNA (0.56) TRPV1RAB9ANPC1CASP3SENP7
SCHEMBL5783405 0.78 TRPV1 (0.76) TRPV1RAB9ANPC1CASP3SENP7
SCHEMBL13544375 0.78 TRPV1 (0.71) TRPV1RAB9ANPC1CASP3SENP7
SCHEMBL13763274 0.77 TRPV1 (0.80) TRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100004222-A1 Amide Derivatives as Ion-Channel Ligands and Pharmaceutical Compositions and Methods of Using the Same RENOVIS, INC. (US) 2010-01-07 US disclosed
US-7576099-B2 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same RENOVIS, INC. (US) 2009-08-18 US disclosed
US-20080300243-A1 Amide Derivatives as Ion-Channel Ligands and Pharmaceutical Compositions and Methods of Using the Same RENOVIS, INC. 2008-12-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100004222-A1 Amide Derivatives as Ion-Channel Ligands and Pharmaceutical Compositions and Methods of Using the Same TRPV1, TRPA1, TRPV2 TRPV1 1/4885RAB9A 2452/4885NPC1 879/4885
US-20080300243-A1 Amide Derivatives as Ion-Channel Ligands and Pharmaceutical Compositions and Methods of Using the Same TRPV1, TRPA1, TRPV2 TRPV1 1/4885RAB9A 2274/4885NPC1 959/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.